Examined lymph node count in non-small-cell lung cancer: will it be a decision making approach in treatment of NSCLC?
- PMID: 28616315
- PMCID: PMC5465119
- DOI: 10.21037/jtd.2017.03.79
Examined lymph node count in non-small-cell lung cancer: will it be a decision making approach in treatment of NSCLC?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.J Clin Oncol. 2017 Apr 10;35(11):1162-1170. doi: 10.1200/JCO.2016.67.5140. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029318 Free PMC article.
References
-
- Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:568-77. - PubMed
-
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Breast Cancer, V.4.2014. - PubMed
-
- National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: Colorectal Cancer, V.2.2013. - PubMed
-
- Liang W, He J, Shen Y, et al. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry. J Clin Oncol 2017;35:1162-1170. 10.1200/JCO.2016.67.5140 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources